0001708138-20-000050.txt : 20200508 0001708138-20-000050.hdr.sgml : 20200508 20200508160306 ACCESSION NUMBER: 0001708138-20-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200507 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zoghbi Huda Y CENTRAL INDEX KEY: 0001681643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20860469 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-07 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001681643 Zoghbi Huda Y 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-05-07 4 M 0 5118 391.92 A 5761 D Common Stock 2020-05-07 4 S 0 1722 565.64 D 4039 D Common Stock 2020-05-07 4 S 0 2128 566.37 D 1911 D Common Stock 2020-05-07 4 S 0 646 567.58 D 1265 D Common Stock 2020-05-07 4 S 0 609 568.37 D 656 D Common Stock 2020-05-07 4 S 0 13 569.2 D 643 D Non-Qualified Stock Option (right to buy) 391.92 2020-05-07 4 M 0 5118 0.0 D 2026-09-09 Common Stock 5118 10235 D Represents volume-weighted average price of sales of 1,722 shares of Company stock on May 7, 2020 at prices ranging from $565.43 to $565.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 2,128 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 646 shares of Company stock on May 7, 2020 at prices ranging from $567.20 to $567.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 609 shares of Company stock on May 7, 2020 at prices ranging from $568.05 to $568.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Huda Y. Zoghbi 2020-05-07